March 9 (Reuters) - Applied Molecular Transport Inc.
AMTI.O :
* APPLIED MOLECULAR TRANSPORT REPORTS FOURTH QUARTER AND
FULL YEAR
2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* APPLIED MOLECULAR TRANSPORT INC. - AS OF DEC 31, 2022,
CASH AND
CASH EQUIVALENTS WERE $61.1 MILLION COMPARED TO $159.8 MILLION
FOR YEAR ENDED DEC 31, 2021
* APPLIED MOLECULAR TRANSPORT INC. - EVALUATING NEXT STEPS
FOR
COMPANY'S SECOND CLINICAL ASSET, AMT-126
* APPLIED MOLECULAR TRANSPORT INC. - EXPLORING STRATEGIC
PARTNERSHIP OPTIONS TO ADVANCE AMT-101 FOR CHRONIC POUCHITIS
* APPLIED MOLECULAR TRANSPORT INC. - QTRLY NET LOSS PER
SHARE,
BASIC AND DILUTED $0.58
Source text for Eikon: ID:nGNX9FL8SY
Further company coverage: AMTI.O
((Reuters.Briefs@thomsonreuters.com;;))